Association between Pterostilbene and Quercetin Inhibits Metastatic Activity of B16 Melanoma  by Ferrer, Paula et al.
Association between Pterostilbene and Quercetin Inhibits
Metastatic Activity of B16 Melanoma1
Paula Ferrer*, Miguel Asensi*, Ramo´n Segarra*, Angel Ortega*, Marı´a Benlloch*, Elena Obrador*,
Marı´a T. Varea y, Gregorio Asensio y, Leonardo Jorda´ z and Jose´ M. Estrela*
Departments of *Physiology and yOrganic Chemistry, University of Valencia, Valencia, Spain; zValefarma SA,
Valencia, Spain
Abstract
Inhibition of cancer growth by resveratrol (trans-3,5,4V-
trihydroxystilbene; RESV), a phytoalexin present in
many plant species, is limited by its low bioavailability.
Pterostilbene (3,5-dimethoxy-4V-hydroxystilbene;
PTER) and quercetin (3,3V,4V,5,6-pentahydroxyflavone;
QUER), two structurally related and naturally occur-
ring small polyphenols, show longer half-life in vivo.
In vitro growth of highly malignant B16 melanoma
F10 cells (B16M-F10) is inhibited (56%) by short-time
exposure (60 min/day) to PTER (40 mM) and QUER
(20 mM) (approximate mean values of plasma con-
centrations measured within the first hour after
intravenous administration of 20 mg/kg of each
polyphenol). Intravenous administration of PTER
and QUER (20 mg/kg per day) to mice inhibits (73%)
metastatic growth of B16M-F10 cells in the liver, a
common site for metastasis development. The anti-
metastatic mechanism involves: 1) a PTER-induced
inhibition of vascular adhesion molecule 1 expression
in the hepatic sinusoidal endothelium, which conse-
quently decreases B16M-F10 cell adhesion to the
endothelium through very late activation antigen 4;
and 2) a QUER- and PTER-induced inhibition of Bcl-2
expression in metastatic cells, which sensitizes them
to vascular endothelium-induced cytotoxicity. Our
findings demonstrate that the association of PTER
and QUER inhibits metastatic melanoma growth and
extends host survival.
Neoplasia (2005) 7, 37–47
Keywords: Polyphenols, pterostilbene, quercetin, melanoma, metastases.
Introduction
Different phenolic compounds, including resveratrol (RESV),
show potent antioxidant effects and may have therapeutic
applications in oxidative stress–related diseases such as
cancer [1–3]. The cancer chemopreventive activity of
RESV was first reported by Jang et al. [4]. The mechanisms
by which RESV exerts its antitumor effects are under active
investigation [3] and may include, for example: 1) inhibition
of ribonucleotide reductase [5], DNA polymerase [6], protein
kinase C [7], or cyclooxygenase-2 [8] activities; 2) inhibition of
reactive oxygen species–mediated carcinogenesis [4] or cell
proliferation [9]; and 3) apoptotic cell death activation [10–13].
However, potential inhibition of cancer growth by RESV is
strongly limited due to its low bioavailability [14]. Thus, struc-
tural modifications of the RESV molecule to increase its
bioavailability while preserving its biologic activity appeared
necessary. The 4V-OH and stereoisometry in its trans-confor-
mation are absolutely required for inhibition of cell proliferation
[15]. Pterostilbene (PTER), a naturally occurring analogue of
RESV but is about 60 to 100 times stronger as an antifungal
agent, shows similar anticarcinogenic properties [16]. Besides,
flavonoids are among the most potent antioxidants because
they show one or more of the following structural elements: an
o-diphenolic group, two to three double bonds conjugated with
the 4-oxo function, and OH groups in positions 3 and 5. Quer-
cetin (QUER) combines all these three properties, and previ-
ous research has confirmed that it also exhibits antitumor
properties, likely due to immune stimulation, free radical scav-
enging, alteration of the mitotic cycle in tumor cells, gene
expression modification, antiangiogenesis activity, apoptosis
induction, or a combination of these effects [2,17]. Because
potential anticancer effects induced by natural polyphenols still
have not been proven effective by systemic administration, we
investigated the anticancer properties of PTER and QUER at
bioavailable concentrations. We found that their association
strongly inhibits the metastatic growth of the highly malignant
B16 melanoma.
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Materials and Methods
Animals and In Vivo Administration of Polyphenols
Mice (C57BL/6J, male, 6–8 weeks) were from Charles
River Spain (Barcelona, Spain). Procedures involving ani-
mals and their care were conducted in conformity with insti-
tutional guidelines that are in compliance with the national
and international laws and policies (European Community
Council Directive 86/609, OJ L 358. 1, December 12, 1987)
and the National Institutes of Health (USA) Guide for the
Care and Use of Laboratory Animals (NIH Publ. No. 85-23,
1985). All animals were fed ad libitum on stock laboratory
diets (Letica, Barcelona, Spain) and kept on a 12-hour light/
12-hour dark cycle with the room temperature maintained
at 22jC. Experiments were started at 10:00 A.M. to minimize
the effects of diurnal variation.
For pharmacokinetic studies and daily treatment, 20 mg
of t-PTER (dissolved in 0.5 ml of ethanol) or QUER (dis-
solved in 0.15 ml of dimethylsulfoxide/physiological saline,
1:0.5) per kilogram was administered intravenously (through
the jugular vein where, previously, a permanent catheter was
surgically fixed; intravenous administration was slowly per-
formed during 1 minute) or orally (through an intragastric
tube) to mice. t-PTER was synthesized in our laboratory
following standard Wittig and Heck reactions (www.orgsyn.
org), whereas QUER was obtained from Sigma Chemical
Co. (St. Louis, MO). 3H-t-PTER (2.2 Ci/mmol), labelled in
ortho and para of benzenic rings, was prepared in our
laboratory following a method similar to that used for deuter-
iation of phenols [18]. 14C-QUER (50 mCi/mmol), labelled
in the 4-position of the C-ring, was obtained from the NCI
Radiochemical Carcinogen Repository at Chemsyn Labora-
tories (Kansas City, MO). Radioactivity was measured using
a Packard 2700TR Varisette analyzer. Blood was collected
through the catheter into 1-ml syringes containing sodium
heparin (0.05 ml of a 5% solution in 6.9% NaCl). Plasma and
erythrocytes were separated as previously described [19].
Determination of PTER and QUER by Liquid
Chromatography and Mass Spectrometry
(LC-MS/MS)
LC-MS/MS was carried out using a Quattro Micro triple–
quadrupole mass spectrometer (Micromass, Manchester,
UK) equipped with a Shimadzu LC-10ADvp. pump and a
SLC-10Avp. controller system with a SIL-10ADvp. autoinjec-
tor. Samples were analysed by reverse-phase high-pressure
liquid chromatography using a Phenomenex (Torrance, CA)
Prodigy ODS column (1002 mm) with 3 mm particle size. In
all cases, 40 ml was injected onto the column. The temper-
ature of the column was maintained at 25jC. The following
gradient system, pumped through the column at 0.2 ml/min,
was used (min/%A /% B/% C) (A, methanol; B, 10% aceto-
nitrile and 90% 10mM ammoniumformate,pH3.75;C,10mM
ammonium formate, pH 3.75): 0/5/5/90, 10/5/5/90, 20/5/90/
5, 30/100/0/0, and 40/5/5/90. Negative ion electrospray
tandem mass spectra were recorded with the electrospray
capillary set at 3.5 keV and a source block temperature of
120jC. Nitrogen was used as the drying and nebulizing gas
at flow rates of 300 and 30 l/hr, respectively. Argon at
1.5103 mbar was used as the collision gas for collision-
induced dissociation. An assay based on LC-MS/MS with
multiple reaction monitoring was developed using the tran-
sitions m/z 255 to 240 for PTER and 300 to 151 for QUER,
both of which represent favorable fragmentation pathways
for these deprotonated molecules. Calibration curves were
obtained using a standard of PTER or QUER (0.01–100 mM)
and, in each case, were found to be linear with correlation
coefficients > 0.99. The limits of detection and quantitation
for our method were of 0.01 mM.
Culture of Tumor Cells
B16M derived from B16M-F10 subline cells were cultured
[20] in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco Laboratories, Grand Island, NY), pH 7.4, supple-
mented with 10 % fetal calf serum (Gibco Laboratories),
10 mM HEPES, 40 mM NaHCO3, 100 U/ml penicillin, and
100 mg/ml streptomycin.
Isolation and Culture of Hepatic Sinusoidal
Endothelium (HSE)
Male C57BL/6J mice (10–12 weeks old) were from IFFA
Credo (L’Arbreole, France) and received care according to
the criteria outlined by the NIH. HSE was separated and
identified as previously described [20]. Sinusoidal cells were
separated in a 17.5% (wt/vol) metrizamide gradient. Cultures
of HSE were established and maintained in pyrogen-free
DMEM supplemented as described above for the B16M-F10
cells. Differential adhesion of endothelial cells to the collagen
matrix and washing allow a complete elimination of other
sinusoidal cell types (Kupffer, stellate, and lymphocytes)
from the culture flasks.
B16 Melanoma–Endothelial Cell Adhesion and Cytotoxicity
Assays
B16M-F10 cells were loaded with 2V,7V-bis-(2-carbox-
yethyl)-5,6-carboxyfluorescein acetoxymethylester (BCECF-AM;
Molecular Probes, Eugene, OR) (106 cells were incubated in
1 ml of HEPES-buffered DMEM, containing 50 mg of BCECF-
AM and 5 ml of DMSO, during 20 minutes at 37jC). After
washing, BCECF-AM–containing cells were resuspended in
HEPES-buffered DMEM without phenol red at a concentra-
tion of 2.5106 cells/ml, and added (0.2 ml/well) to endothe-
lial cells (plated 24 hours before) and also to plastic- or
collagen-precoated control wells. The plates were then incu-
bated at 37jC and, 20 minutes later, the wells were washed
three times with fresh medium and read for fluorescence
using a Fluoroskan Ascent FL (Labsystems, Manchester,
UK). The number of adhering tumor cells was quantified by
arbitrary fluorescence units based on the percentage of the
initial number of B16M-F10 cells added to the HSE culture
[20]. Damage to B16M-F10 cells during their in vitro adhe-
sion to the HSE was measured, as previously described [21],
using tumor cells loaded with calcein-AM (Molecular
Probes). The integrity of B16M-F10 cells cultured alone
was assessed by trypan blue exclusion and by measuring
lactate dehydrogenase activity released to the extracellular
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medium [22]. Other reagents used in experiments of tumor
cytotoxicity were from Sigma.
Cytokines
Recombinant murine TNF-a (2107 U/mg protein) and
recombinant murine interferon-g (IFN-g; 105 U/mg protein)
were obtained from Sigma. Stock solutions (5105 U of
TNF-a/ml and 25104 U of IFN-g/ml) were diluted in sterile
physiological saline solution (0.9 % NaCl), adjusted to pH
7.0, and stored at 4jC.
Assay for In Vitro Invasion of Hepatic Endothelial Cell
Monolayer by B16 Melanoma Cells
Invasion of endothelial cell monolayer by B16M-F10 cells
was assayed in accordance with the method by Ohigashi
et al. [23] with some modifications. HSE cells were seeded
on (1%) gelatin-coated tissue culture dishes with grids.
When the cells reached confluency, the culture medium
was replaced with fresh medium. After a 2-hour incubation,
the cultures were washed with DMEM and then B16M-F10
cells were cultured on overlayered HSE cells for 5 days. The
invasion capacity of B16M-F10 cells was measured by
counting the number of colonies per 1 cm2 formed under
the HSE monolayer using a phase contrast microscope.
Calculation of the Interaction Index of a Combination
The method used is described by Berenbaum [24] where
the interactive response for a combination of two compounds
is expressed as: dA/DA + dB/DB = 1, where dA and dB
represent values of concentrations of two agents (A and B) in
combination (40 mM t-PTER and 20 mM QUER, in our case;
see the legend to Figure 2). Dose–response curves of
agents A and/or B (where the y-axis represents the percent
of inhibition of cell growth in vitro and the x-axis represents
the concentration of each polyphenol) will indicate at which
concentrations A, B, and A + B are isoeffective. If the equa-
tion results in a value significantly less than one, synergism
will be inferred; if more, then antagonism will be inferred.
Measurement of H2O2, Nitrite, and Nitrate
The assay of H2O2 production was based on the H2O2-
dependent oxidation of homovanillic acid (3-methoxy-4-
hydroxyphenylacetic acid) to a highly fluorescent dimer
(2,2V-dihydroxydiphenyl-5,5V-diacetic acid), which is mediat-
ed by horseradish peroxidase [20]. For this purpose, cells
were cultured in the presence of 100 mM homovanillic acid
and 1 U/ml horseradish peroxidase. A linear relationship
between fluorescence (kexcitation = 312 nm and kemission =
420 nm) and amount of H2O2 was found in the range of 0.1
to 12 nmol per 2-ml assay.
Nitrite and nitrate determinations were performed using
the methodology of Braman and Hendrix [25]. Briefly, mea-
surement of NO2
 levels were made by monitoring NO
evolution through chemiluminescence detection from a
measured sample placed into a refluxing solution of iodide/
acetic acid (which will only reduce NO2
 and not NO3
 to NO).
Total NOx (NO2
 plus NO3
) determinations were made by
monitoring NO evolution from a measured sample placed
into a boiling VCl3/HCl solution (which will reduce both NO2

and NO3
 to NO). The determination of NO3
 levels was
made by subtracting the value for NO2
 from the NOx value.
Quantitation was accomplished using a standard curve
made up of known amounts of NO2
 and NO3
.
Flow Cytometry
Expression of intercellular adhesion molecules was ana-
lyzed by flow cytometry [26]. For this purpose, B16M-F10
cells (1106) were incubated with 1 mg of antimouse very late
activation antigen 4 (VLA-4) monoclonal antibody (type rat
IgG2b, clone PS/2; Serotec, Oxford, UK) for 1 hour at 4jC.
HSE (1106 cells) was incubated with 2 mg of antimouse
vascular adhesion molecule 1 (VCAM-1) monoclonal anti-
body (type rat IgG, kappa, clone M/K-2; R&D Systems,
Minneapolis, MN). B16M-F10 and HSE cells were washed
with PBS twice, then were treated with fluorescein isothio-
cyanate– labeled goat antirat immunoglobulin antibody
(Serotec) for 1 hour at 4jC. After washing with PBS twice,
the cells were analyzed on a fluorescence-activated cell
sorter (FACScan; Becton Dickinson, Sunnyvale, CA). Prolif-
eration and/or viability of B16M-F10 and HSE cells was not
affected by these monoclonal antibodies (even by adding
up to 100 mg/ml antibody to the culture medium) (data
not shown).
RT-PCR and Detection of mRNA Expression
Total RNA was isolated using the Trizol kit from Invitrogen
(San Diego, CA) and following manufacturer’s instructions.
cDNA was obtained using a random hexamer primer and a
MultiScribe Reverse Transcriptase kit as described by the
manufacturer (TaqMan RT Reagents; Applied Biosystems,
Foster City, CA). A PCRmaster mix and AmpliTaq Gold DNA
polymerase (Applied Biosystems) were then added contain-
ing the specific primers:
Real-time quantitation of each mRNA relative to glycer-
aldehyde-3P-dehydrogenase (GAPDH) mRNA was per-
formed with an SYBR Green I assay and an iCycler
BAX Forward 5V-AAGCTGAGCGAGTGTCTCCGGCG
Reverse 5V-GCCACAAAGATGGTCACTGTCTGCC
BAK Forward 5V-AGTGAGGGCAGAGGTGAGAGTICA
Reverse 5V-CACAGTTGCTTCTGCTGGAGTAGTT
BAD Forward 5V-CCAGTGATCTTCTGCTCCACATCCC
Reverse 5V-CAACTTAGCACAGGCACCCGAGGG
BID Forward 5V-ACAAGGCCATGCTGATAATGACAAT
Reverse 5V-CAGATACACTCAAGCTGAACGCAG
Bcl-2 Forward 5V-CTCGTCGCTACCGTCGTGACTTCG
Reverse 5V-CAGATGCCGGTTCAGGTACTCAGTC
Bcl-w Forward 5V-CGAGTTTGAGACCCGTTTCCGCC
Reverse 5V-GCACTTGTCCCACCAAAGGCTCC
Bcl-xL Forward 5V-TGGAGTAAACTGGGGGTCGCATCG
Reverse 5V-AGCCACCGTCATGCCCGTCAGG
GAPDHForward 5V-CCTGGAGAAACCTGCCAAGTATG
Reverse 5V-GGTCCTCAGTGTAGCCCAAGATG
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detection system (BioRad, Hercules, CA). Target cDNA
were amplified in separate tubes using the following:
10 minutes at 95jC, then 40 cycles of amplification (dena-
turation at 95jC for 30 seconds, and annealing and exten-
sion at 60jC for 1 minute per cycle). The increase in
fluorescence was measured in real time during the extension
step. The threshold cycle (CT) was determined, and then the
relative gene expression was expressed as: fold change =
2–D(DCT) , where DCT = CT targetCT GAPDH, and D(DCT) =
DCT treated  DCT control.
Bcl-2 Gene Transfer and Analysis
The Tet-off gene expression system (Clontech, Palo Alto,
CA) was used, as previously reported [27], to insert the
mouse Bcl-2 gene and for transfection into B16M-F10 cells
following the manufacturer’s instructions. Bcl-2 protein was
quantitated in the soluble cytosolic fraction by enzyme immu-
noassay [28] using a monoclonal antibody-based assay from
Sigma (one unit of Bcl-2 was defined as the amount of Bcl-2
protein in 1000 nontransfected B16M cells).
Western Blots
Cultured cells were harvested, as indicated above, and
then washed twice in ice-cold Krebs-Henseleit bicarbonate
medium (pH 7.4). Whole cell extracts were made by freeze–
thaw cycles in a buffer containing 150 mM NaCl, 1 mM
EDTA, 10 mM Tris–HCl, 1 mM phenylmethylsulfonyl fluo-
ride, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml
pepstatin, pH 7.4. Fifty micrograms of protein (as determined
by the Bradford assay) were boiled with Laemmli buffer and
resolved in 12.5% sodium dodecyl sulfate polyacrylamide
gel electrophoresis. Proteins were transferred to a nitrocel-
lulose membrane and subjected to Western blotting with
antimouse Bcl-2 monoclonal antibody (clone YTH-10C4;
Trevigen, Gaithersburg, MD). Blots were developed using
horseradish peroxidase–conjugated secondary antibody
and enhanced chemiluminiscence (ECL system; Amersham,
Arlington Heights, IL).
Experimental Metastases
Hepatic metastases were produced by intravenous in-
jection (portal vein) into anesthesized mice (Nembutal;
50 mg/kg ip) of 4105 viable B16M-F10 cells suspended in
0.2 ml of DMEM. Mice were cervically dislocated 10 days
after B16M-F10 inoculation. The livers were fixed with 10%
formaldehyde in PBS (pH 7.4) for 24 hours at 22jC and then
paraffin-embedded. Metastasis density (mean number of
foci/100 mm3 of liver detected in fifteen 1010 mm2 sections
per liver) and metastasis volume (mean percent of liver
volume occupied by metastasis) were determined as earlier
described [22].
In vivo microscopy to follow metastatic cell dynamics
within the liver was performed, as earlier described [21],
using calcein-AM–labeled (Molecular Probes) B16M-F10
cells. The total number of calcein-AM–labeled cells per
hepatic lobule was recorded in 10 different lobules per liver
at 15-minute intervals for a 6-hour period. The microscope
was an Eclipse E600FN, providing transillumination or epi-
illumination, equipped for video microscopy using a digital
DXM 1200 camera (Nikon, Tokyo, Japan).
Isolation of B16M-F10 Cells from Liver Metastases
and Determination of Cell Volume
Invasive B16M-F10 cells were isolated, as previously
described, using anti–Met-72 monoclonal antibodies and
flow cytometry–coupled cell sorting (EPICS ELITE; Coulter
Electronics, Hieleah, FL) [29]. Anti–Met-72 monoclonal anti-
bodies, which react with a 72-kDa cell surface protein
(Met-72) expressed at high density on B16M clones of high
metastatic activity, were produced as described by Kimura
and Xiang [30].
Invasive cells suspended in Krebs-Henseleit bicarbon-
ate medium (pH 7.4) were centrifuged through a layer of
silicone oil (AR200; Serva, Heidelberg, Germany). The
presence of 3H2O (2.5 mCi/ml) (Amersham, Bucks, UK)
in the cell suspension allows calculation, after centrifuga-
tion, of the radioactivity accumulated in the intracellular
compartment [22].
Expression of Results and Statistical Significance
Data are presented as mean ± SD for the indicated
number of different experiments. Statistical analyses were
performed using Student’s t test and P < .05 was considered
significant.
Results
Plasma Levels of PTER and QUER
Depending on dietary habits, the human intake of fla-
vones and flavonols (the most common flavonoids) isf3 to
70 mg/day, mainly QUER (60–75%) (major sources include
tea, wine, berries, apples, and onions) [31]. However, there
are no reported estimations regarding PTER intake, which
is present, for example, in extracts of the heartwood of
Pterocar marsupium, which is used in Ayurvedic medicine
for the treatment of diabetes, and in dark-skinned grapes
(although quantitative studies have shown that for every
10 parts of RESV, there are only one to two parts of PTER)
(Ref. [16] and references therein). As shown in Figure 1, after
intravenous administration to mice of 20 mg/kg t-PTER or
QUER (a dose that is representative for an adult human
being of 70 kg body weight f1000 times the maximum
amount of PTER found in 1 kg of dark grapes, and f20
times the maximum daily intake of QUER), their highest
concentration in plasma (f95 mMPTER andf46 mMQUER
5 minutes after administration) decreased to f1 mM in
480 minutes (PTER) to 120 minutes (QUER). Following an
identical protocol, we found previously that the highest RESV
concentration in plasma (f43 mM 5 minutes after intrave-
nous administration to rabbits) decreased rapidly to f1 mM
in 60 minutes [14]. We calculated a half-life of RESV in
mouse plasma off10.2 minutes (Estrela et al., unpublished
data). From the data in Figure 1, we calculated a half-life of
PTER and QUER of f77.9 and 20.1 minutes, respectively
(Figure 1). Data reported in Figure 1 for each polyphenol
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were not significantly different when PTER and QUER
were administered together (not shown). Total blood levels
of PTER or QUER in mice were not significantly different
from those reported above for plasma (not shown). At least
99% of the PTER measured in plasma or blood was in the
trans form.
For comparison, t-PTER or QUER (20 mg/kg) was also
administered orally. A mixture of 3H-t-PTER (5 mCi/mouse)
and unlabeled t-PTER or 14C-QUER (2 mCi/mouse) and
unlabeled QUER was administered in order to differentiate
between free nonmodified polyphenols and their metabo-
lites/conjugates generated under in vivo conditions. For
calculations, free forms were measured by LC/MS-MS
(under Materials and Methods section). Then, after correct-
ing for dilutions, radioactivity in samples containing only free
PTER or QUER was subtracted from the total radioactivity
measured in an equivalent plasma sample. As shown in
Table 1, after oral administration, plasma levels of PTER and
QUER peaked at 60 and 10 minutes, respectively. However,
total levels of PTER and QUER (free unchanged polyphe-
nols plus their metabolites and conjugated forms) were very
different. Total PTER concentration was > 10 mM between 30
and 240 minutes after administration, whereas total QUER
levels only remained >1 mMwithin the first 10minutes (Table 1).
During those time periods, free PTER represented a small
percent of the total (15–35%), whereas free QUER (except-
ing the first 5 minutes) was almost undetectable (< 0.5%)
(Table 1).
Extravascular Levels of PTER and QUER
In order to complement plasma/blood pharmacokinetics
following intravenous administration (Figure 1), we also eval-
uated extravascular tissue bioavailability of PTER and
QUER. As shown in Table 2, after their intravenous admin-
istration to mice, the highest content of PTER or QUER in
the brain, lung, liver, and kidney was found within the first
5 minutes after administration (Table 2). Therefore, it appears
that both polyphenols do not accumulate extravascularly and
that their presence in different tissues (Table 2) parallels in
time their bioavailability in the bloodstream (Figure 1).
Nevertheless, it is important to remark the different pharma-
cokinetics obtained for both polyphenols when oral and
intravenous administrations are compared (Figure 1 and
Table 1). PTER and QUER were practically undetectable in
plasma at 60 and 240 minutes, respectively, after their
intravenous administration; whereas both polyphenols were
detectable even 720 minutes after their oral administration.
These facts are the obvious consequence of absorption and
metabolism at the digestive tract, in which PTER and QUER
must also be different (as suggested by the data in Table 1).
Inhibition of B16 Melanoma Cell Growth In Vitro
The highly aggressive B16 melanoma F10 (B16M-F10) is
a model widely used to study metastatic spread and tissue
invasion [21], and thus was selected for our studies. In the
first set of experiments, the effect of t-PTER and QUER on
B16M-F10 cell growth was followed in vitro. To mimic in vivo
conditions after intravenous administration, we incubated
B16M-F10 cells in the presence of t-PTER (40 mM) and/or
QUER (20 mM) for a limited period (60 minutes) (this repre-
sents an approximate mean value of the concentrations of
PTER and QUER measured in plasma during the first hour
after intravenous administration of 20 mg/kg of each poly-
phenol) (Figure 2). For comparison, we also used t-RESV
(12 mM; a similar criterion was followed to select this con-
centration; see data reported in Ref. [14]). Polyphenols were
added to the incubation medium each 24 hours and, as
indicated, were present only for 60 minutes. As shown in
Figure 1. Plasma levels and half-life of pterostilbene and quercetin after their intravenous administration to mice. Animals were treated with 20 mg of t-PTER or
QUER per kilogram body weight. Plasma levels were determined as explained under Materials and Methods section. Results are mean ± SD for five to six mice per
time point.
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Figure 2, t-PTER and QUER inhibited B16M-F10 growth by
f40 and 19%, respectively. However, when both were
present, cancer growth inhibition increased tof56%, which
suggests a possible additive/synergic effect. To test this
possibility, we performed dose–response studies (data not
shown) and calculated the interaction index of the combina-
tion of t-PTER and QUER (see the Materials and Methods
section) and found a value of 0.74 ± 0.05 (n = 5), which
indicates synergy. In the experiments reported in Figure 2,
cell cycle distribution (approximate percent of cells in G0/G1,
S, and G2/M phases, n = 6, in all cases) was 58.0 ± 5.5, 22.4
± 3.7, and 19.6 ± 2.6 in controls growing exponentially; 74.0
± 4.4, 11.4 ± 1.7, and 14.6 ± 2.7 in t-PTER–treated cells;
65.3 ± 5.2, 15.8 ± 2.8, and 18.9 ± 2.0 in QUER-treated cells;
and 77.7 ± 7.1, 13.2 ± 1.4, and 9.1 ± 1.6 in t-PTER– and
QUER-treated cells (cell viability remained >95% in all
cases). Therefore, despite their different percentages of
tumor cell growth inhibition, both polyphenols tend to induce
accumulation inG0/G1. In our experimental conditions, t-RESV
did not affect significantly the rate of tumor cell growth
(Figure 2). Moreover, t-RESV did not affect significantly the
percentage of B16M-F10 growth inhibition (Figure 2) or the
cell cycle distribution found in the presence of t-PTER and/
or QUER.
Also for comparison, we incubated B16M-F10 cells in the
presence of t-PTER and QUER at concentrations that rep-
resent an approximate mean value of the total level of each
polyphenol measured in plasma within the first hour after
oral administration (11 mM PTER and 1 mMQUER) (Table 1).
Both polyphenols, as free forms, were present constantly in
the incubation medium. Although both PTER and QUER
follow metabolic transformations after oral administration,
the use of free forms is a valid approach because their
metabolites/conjugates are not expected to show stronger
antitumor activity (e.g., Refs. [32,33]). However, under these
conditions, t-PTER (11 mM) and/or QUER (1 mM) did not
affect significantly the control rates of B16M-F10 cell growth
in vitro (similar control rates reported in Figure 2) (data not
shown). Total levels of free polyphenols added to the incu-
bation medium did not change along the culture time, indi-
cating that cancer cells do not metabolize/conjugate t-PTER
or QUER (not shown).
Interaction between B16 Melanoma and Endothelial Cells
In Vitro
In addition to the effect of PTER and QUER on tumor cell
growth in vitro, other potential antimetastatic mechanisms
were investigated. First, the interaction of B16M-F10 cells
and the HSE was studied in vitro. Based on the results
obtained above, we selected the short-term (60 minutes)
exposure of metastatic cells to polyphenols [at the concen-
trations measured in plasma after their intravenous admin-
istration: t-RESV (12 mM), t-PTER (40 mM), and/or QUER
(20 mM)]. Because the interaction of metastatic cells with
endothelial and Kupffer cells activates local release of proin-
flammatory cytokines, which promote cancer cell adhesion to
the endothelium and invasion [14,34], we investigated the
effect of polyphenols on B16M-F10 cell adhesion to the HSE
in the presence of TNF-a and IFN-g (this cytokine combina-
tion fully activates the HSE; e.g., Ref. [20] and references
therein) (Table 3). As previously reported [14], t-RESV
inhibits tumor cell adhesion to the endothelium (f47%)
Table 1. Plasma Levels of Pterostilbene and Quercetin after Their Oral
Administration to Mice.
Time (min) PTER QUER
(mM) (% Free) (mM) (% Free)
5 2.9 ± 0.6 67 ± 13 1.6 ± 0.3 22 ± 6
10 6.6 ± 1.8* 50 ± 10 2.3 ± 0.7 < 0.5*
30 11.1 ± 3.0* 35 ± 5* 0.6 ± 0.2* < 0.5*
60 18.2 ± 2.7* 17 ± 6* 0.2 ± 0.1* < 0.5*
120 13.3 ± 3.4* 15 ± 3* 0.07 ± 0.01* < 0.5*
240 10.6 ± 1.2* 16 ± 4* 0.05 ± 0.02* < 0.5*
480 7.1 ± 0.8* 14 ± 4* 0.05 ± 0.02* < 0.5*
720 1.6 ± 0.5* 12 ± 2* 0.04 ± 0.01* < 0.5*
1440 n.d. n.d. n.d. n.d.
Animals were treated with 20 mg of t-PTER or QUER per kilogram body
weight. A group of six to seven mice was sacrificed for each time point.
Nondetectable = n.d.
*P < .01 comparing data obtained at 10 to 1440 minutes versus those found
5 minutes after polyphenol administration.
Table 2. Extravascular Levels of Pterostilbene and Quercetin after Their
Intravenous Administration to Mice.
Time Brain Lung Liver Kidney
PTER QUER PTER QUER PTER QUER PTER QUER
5 5 ± 1 4 ± 1 36 ± 6 15 ± 3 14 ± 4 9 ± 3 3 ± 1 1 ± 0.2
10 2 ± 0.5* 2 ± 0.4* 15 ± 3* 8 ± 2* 7 ± 1* 3 ± 1* 3 ± 0.3 1 ± 0.5
30 n.d. n.d. 6 ± 1* 2 ± 0.6* 3 ± 0.5* 1 ± 0.2* 2 ± 0.4 n.d.
60 n.d. n.d. 2 ± 1* n.d. n.d. n.d. 1 ± 0.3* n.d.
Animals were treated with 20 mg of t-PTER or QUER (containing 5 mCi of
3H-t-PTER or 2 mCi of 14C-QUER) per kilogram body weight. A group of four
to five mice was sacrificed for each time point.
Nondetectable = n.d.
*P < .01 comparing data obtained at 10 to 60 minutes versus those found
5 minutes after polyphenol administration.
(min)
Figure 2. In vitro inhibition of B16M-F10 cell growth by short-time exposure to
resveratrol, pterostilbene, and/or quercetin. B16M-F10 cells were cultured for
72 hours. t-RESV (12 M), t-PTER (40 M), and QUER (20 M) were added
at 6, 30, and 54 hours of culture time, and were present each time for only
60 minutes. After the 60-minute period in the presence of polyphenols, the
culture flasks were washed out (three times with PBS) and the medium was
renewed. All points are mean ± SD for five to six independent experiments.
*P < .05, **P < .01 compared to control values.
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without increasing HSE-induced metastatic cell cytotoxicity.
A similar effect (f60% inhibition of adhesion) is found in
the presence of t-PTER (Table 3). On the contrary, QUER
increases HSE-induced B16M-F10 cell death (f48%) but
without affecting the rate of adhesion (Table 3). As shown in
Table 3, by combining t-PTER and QUER, we obtained the
lowest percentage of B16M.F10 cell adhesion to the HSE
and the highest percentage of cytotoxicity in the adhered
cancer cells. Assaying the in vitro invasion of hepatic endo-
thelial cell monolayers by B16M-F10 cells, we found a
marked decrease (f74%) in the number of penetrated
colonies in the presence of t-PTER and QUER (Table 3).
Adhesion of B16M-F10 cells to the HSE induces endo-
thelial NO and H2O2 release, leading to metastatic cell killing
[20]. We found that H2O2 was not cytotoxic in the absence of
NO; however, NO-induced tumor cytotoxicity was increased
by H2O2 due to the formation of potent oxidants such as
.OH
and ONOO radicals through a trace metal–dependent
process [20]. We found that, during B16M-F10 and HSE
interaction in the presence of t-PTER and QUER (both
present x60 minutes as in Table 3), NOx accumulated in
the cultured medium during a 3-hour period was not sig-
nificantly different from controls (7.5 ± 1.3 nmol/106 cells;
n = 6). However, t-PTER and QUER decreased H2O2
generation from 70 ± 12 nmol/106 cells (controls) to 34 ±
10 nmol/106 cells (n = 5–6 in both cases, P < .01). There-
fore, an increase in endothelial NO and H2O2 release cannot
be argued as a potential antimetastatic mechanism in our
model. Although, obviously, other mechanism(s) activated
by t-PTER and/or QUER must favor the decrease in meta-
static activity shown in Table 3.
Expression of Intercellular Adhesion Molecules
In order to further elucidate the underlying molecular
mechanisms, we also used flow cytometry analysis to mea-
sure VLA-4 and VCAM-1 expression in B16M-F10 and HSE
cells, respectively, cultured in the presence of t-PTER (40 mM)
and/or QUER (20 mM). Interaction between VLA-4 on
B16M cells and VCAM-1 on activated endothelial cells is a
necessary step in the metastatic process [26]. As shown in
Table 4, flow cytometric analysis revealed that B16M-F10
and HSE cells expressed high levels of VLA-4 and VCAM-1,
respectively, on their surfaces, and that, as previously
reported for t-RESV [14], t-PTER decreased VCAM-1 in
HSE cells (Figure 3). We found no statistical differences
when VCAM-1 levels determined after exposure to PTER or
the combination of PTER and QUER were compared (not
shown). This mechanism may explain the inhibitory effect of
PTER on B16M-F10 and HSE intercellular adhesion.
Expression of Prodeath and Antideath Bcl-2 Genes in B16
Melanoma Cells
Recently, RT-PCR expression analysis of a Bcl-2 family
of genes revealed that B16M-F10 cells (high metastatic
potential), compared with B16M-F1 cells (low metastatic
potential), overexpressed preferentially Bcl-2 [35]. There-
fore, because Bcl-2 overexpression can increase metastatic
cell resistance against oxidative and nitrosative stress [35],
changes in the expression of prodeath and/or antideath Bcl-2
genes could be related to the increase in endothelium-
induced B16M-F10 cytotoxicity elicited by QUER (Table 3).
We studied this question by analyzing the effect of t-PTER
and/or QUER on the expression of death-related Bcl-2
genes. As shown in Table 5, t-PTER increases the expres-
sion of prodeath BAX (f2.2-fold) and decreases expression
of antideath Bcl-2 (f2.2-fold). Besides, QUER increases the
Table 3. Effect of Short-Time Exposure to Resveratrol, Pterostilbene, and/or
Quercetin on the In Vitro Interaction between B16M-F10 Cells and the
Vascular Endothelium.
Additions Tumor Cell Number of Penetrated
Adhesion (%) Cytotoxicity
(% Adhered Cells)
None 100 ± 15 15 ± 2 157 ± 17
RESV 53 ± 7* 12 ± 3 104 ± 12*
PTER 40 ± 6* 19 ± 3y 89 ± 9*
QUER 98 ± 11 52 ± 6* 106 ± 15*
RESV + PTER 32 ± 4* 17 ± 4 77 ± 8*
RESV + QUER 55 ± 7* 55 ± 7* 70 ± 7*
PTER + QUER 37 ± 5* 54 ± 5* 41 ± 5*
Twenty-four-hour cultured HSE cells [± polyphenol(s), added 12 hours after
plating and removed by washing 60 minutes later] were cocultured with
72-hour cultured B16M cells [± polyphenol(s), as in Fig. 2]. Cytokines [100 U/ml
TNF-a and 50 U/ml IFN-g; see Ref. [20]] or vehicle (physiological saline) were
added to the culture media 12 hours before starting cocultures. The ratio of
tumor cells adhering to the HSE wasf1:1 in cytokine-treated cultures in the
absence of polyphenols (a 100% adhesion rate was given to this value). In
B16M endothelial cell adhesion experiments, 20 minutes after B16M addition
to the HSE, the plates were washed as described under Materials and
Methods section. In endothelium-induced B16M cytotoxicity assays, tumor
cytotoxicity (expressed as the percentage of tumor cells that lost viability
within the 4- to 6-hr period of incubation; see Materials and Methods section)
was determined after 6 hours of incubation. During the 6-hour period of
incubation, the percentage of HSE cell viability was 99–100% in all cases. All
assays were performed in the absence or in the presence of t-RESV (12 mM),
t-PTER (40 mM), and/or QUER (20 mM). Values represent mean ± SD of five
to six different experiments in each case.
*P < .01 by comparing incubations in the presence and in the absence
of polyphenol(s).
yP < .05.
Table 4. Effect of Pterostilbene and/or Quercetin on the Expression of VLA-4
on B16M-F10 Cells and of VCAM-1 on HSE Cells.
DFL1
No Additions PTER QUER PTER + QUER
B16M-F10 12 ± 3 16 ± 3 10 ± 2 14 ± 3
B16M-F10 + anti –VLA-4 159 ± 27 168 ± 31 144 ± 32 150 ± 21
HSE 36 ± 6 25 ± 6 30 ± 5 28 ± 4
HSE + anti –VCAM-1 266 ± 44 107 ± 19* 242 ± 53 116 ± 17*
VLA-4 and VCAM-1 expression was analyzed by flow cytometry as ex-
plained under Materials and Methods section. B16M-F10 and HSE cells
[± polyphenol(s)] were cultured and then cocultured in the presence of TNF-a
and IFN-g, as indicated in the legend to Table 3. Cells were harvested (see
under Materials and Methods section), washed twice in ice-cold fresh PBS,
and resuspended in DMEM before starting incubations with antibodies.
Assays were performed in the absence or in the presence of t-PTER (40 mM)
and/or QUER (20 mM). Results are expressed as fluorescence intensity
(DFL1) and represent mean ± SD of four to five different experiments in each
case.
*P < .01 by comparing incubations in the presence and in the absence of
polyphenol(s).
Colonies Per cm2
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expression of all prodeath genes analyzed (BAX, BAK, BAD,
and BID) (e.g., BAX; f2.5-fold) and decreases the expres-
sion of all antideath genes analyzed (Bcl-2, Bcl-w, and
Bcl-xL) (e.g. Bcl-2; f7.3 fold) (Table 5). Gene expression
analysis was similar when data obtained in the presence of
QUER or in the presence of t-PTER and QUER were
compared (Table 5). These effects may explain the increase
in tumor cytotoxicity elicited by the endothelium in the
presence of t-PTER and QUER (Table 3).
Metastatic Growth in the Liver
Finally, the effect of PTER and/or QUER was also studied
in vivo. For this purpose, mice were inoculated with control
B16M-F10 or Bcl-2–overexpressing B16M-F10/Tet-Bcl-2
cells. Both cell subsets were previously cultured in the
absence or in the presence of t-PTER and/or QUER. As
shown in Table 6 and Figure 4, t-PTER and/or QUER
decreases intracellular Bcl-2 levels; although in agreement
with the data in Table 5, this effect was more evident in the
presence of QUER. Besides, also in agreement with our
results in Tables 3 and 4, t-PTER or t-PTER + QUER decreased the number of arrested B16M-F10 and B16M-
F10/Tet-Bcl-2 cells (no significant differences were found
when results obtained in the presence of PTER or the
polyphenol combination were compared). However, given
the different Bcl-2 levels between both cell subsets, QUER
and t-PTER + QUER only decreased the percentage of
intact arrested cells in control B16M-F10 cells (Table 6). In
consequence, although untreated mice inoculated with
B16M-F10 or B16M-F10/Tet-Bcl-2 cells showed similar rates
Table 6. Metastatic Growth in the Liver of Mice Intrasplenically Injected with
B16M-F10 Cells Treated with Pterostilbene and Quercetin and Containing
Different Bcl-2 Levels.
Additions Melanoma
B16M-F10 B16M-F10/
tet-Bcl-2
Intracellular Bcl-2
levels before inoculation
(U/mg protein)
NONE 35 ± 5 160 ± 25
PTER 21 ± 4* 151 ± 18y
QUER 9 ± 3* 125 ± 13z,y
PTER + QUER 7 ± 2* 118 ± 16*,y
Number of arrested
cells (average number
per lobule)
NONE 45 ± 7 42 ± 6
PTER 20 ± 5* 21 ± 4*
QUER 46 ± 9 40 ± 7
PTER + QUER 18 ± 4* 17 ± 3*
Intact cells (% of
arrested cells)
NONE 83 ± 14 85 ± 13
PTER 85 ± 17 91 ± 20
QUER 52 ± 8* 87 ± 13y
PTER + QUER 48 ± 10* 90 ± 17y
Metastasis density
(number of
foci/100 mm3)
NONE 27 ± 5 29 ± 5
PTER 18 ± 4* 15 ± 3*
QUER 15 ± 4* 26 ± 5y
PTER + QUER 7 ± 2* 20 ± 4z,y
Metastasis volume
(% liver volume)
NONE 22 ± 4 25 ± 6
PTER 14 ± 4* 15 ± 3*
QUER 12 ± 3* 24 ± 5y
PTER + QUER 6 ± 2* 19 ± 5y
Host survival (days) NONE 13 ± 2 12 ± 1
PTER 15 ± 2 12 ± 2
QUER 15 ± 1 13 ± 2
PTER + QUER 27 ± 3* 14 ± 2y
B16M-F10 cells were culturedn  72 hours in the absence or in the presence
of t-PTER (40 M) and/or QUER (20 M), as indicated in the caption to Fig. 2.
Bcl-2 levels in control (none under additions) and Tet-Bcl-2 – treated B16M-
F10 cells were measured, in 72-hour cultured tumor cells, before inoculation.
The number of arrested cells displayed on the table was calculated at
60 minutes postinjection (no significant differences were found when mea-
surements were performed at 30, 120, 180, 240, or 360 minutes postinjection;
not shown). The number of intact cells was calculated at 6 hours post-
injection. In in vivo microscopy experiments, data are mean ± SD for four to
five independent tests. Metastatic growth in the liver was evaluated as
indicated under Materials and Methods section and, in this case, mice were
treated daily (10 days) with 20 mg of t-PTER and 20 mg of QUER per kilo-
gram body weight administered intravenously (data are mean ± SD of 25 mice
per group). A similar procedure and identical number of mice per group were
used to evaluate host survival. The significant test refers, for all groups, to the
comparison between PTER + QUER and no additions (zP < .05 and *P < .01),
and also to the comparison between B16M-F10/Tet-Bcl-2 vs control B16M-
F10 cells (yP < .01).
Figure 3. Flow cytometric analysis of VCAM-1 on HSE cells. Flow cytometry
was performed (see the legend to Table 4) on cultured endothelial cells
incubated in the absence or in the presence of t-PTER (40 M). Black
histogram: control cells. Grey histogram: t-PTER– treated cells. Results
shown are representative of five different experiments.
Table 5. Effect of Pterostilbene and/or Quercetin on the Expression of
Prodeath and Antideath Bcl-2 Genes in B16M-F10 Cells.
Gene Additions
None PTER QUER PTER + QUER
BAX 1.0 ± 0.1 2.2 ± 0.3* 2.5 ± 0.3* 2.5 ± 0.5*
BAK 1.2 ± 0.2 1.0 ± 0.1 1.6 ± 0.2y 1.3 ± 0.2
BAD 0.9 ± 0.1 1.1 ± 0.1 2.3 ± 0.3* 2.2 ± 0.3*
BID 1.0 ± 0.1 1.2 ± 0.2 1.5 ± 0.1* 1.5 ± 0.1*
Bcl-2 1.1 ± 0.2 0.5 ± 0.1* 0.15 ± 0.05* 0.15 ± 0.05*
Bcl-w 1.2 ± 0.1 0.9 ± 0.1y 0.8 ± 0.2* 0.8 ± 0.2*
Bcl-xL 1.2 ± 0.2 0.8 ± 0.2 0.6 ± 0.1* 0.7 ± 0.2*
B16M-F10 cells were cultured  72 hours in the absence or in the presence
of t-PTER (40 mM) and/or QUER (20 mM), as indicated in the caption to Fig. 2.
The data, expressing fold change (see under Materials and Methods section
for calculations), show mean values ± SD for five to six different experiments.
*P < .01 comparing polyphenols versus no additions.
yP < .05.
Figure 4. Western blot analysis of Bcl-2 in B16M-F10 cells. B16M-F10 cells
were cultured 72 hours in the absence or in the presence of t-PTER (40 M)
or QUER (20 M) (see the legend to Table 6). Lane a, QUER; lane b, t-PTER;
lane c, control untreated cells.
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of metastatic growth in the liver and similar host survival, the
effect of daily intravenous administration of t-PTER + QUER
was more evident in control B16M-F10 cells: f74% de-
crease in metastasis density and volume and a two-fold
increase in host survival (Table 6). Although both PTER or
QUER showed similar antimetastatic potential (f34% and a
45% decrease in metastasis density and volume, respec-
tively), this was not associated with a significant increase in
host survival. This fact suggests that PTER or QUERmay be
causing clonal selection of highly proliferating and resistant
cancer cells [36,37], an aggressive cell subset whose growth
may possibly be further decreased when both polyphenols
are present. Obviously, an answer to this hypothesis will
require further investigations.
Furthermore, it also possible that polyphenol combination
that causes in vitro growth inhibition could also associate
with a significant decrease in tumor cell volume within the
liver metastases in vivo. To answer this question, we isolated
B16M-F10 cells from their hepatic metastasis using anti–
Met 72 monoclonal antibodies and flow cytometry–coupled
cell sorting (see details of this recent methodology in Ortega
et al. [29]). Then, cell volume of the isolated metastatic cells
was quantified using 3H2O and centrifugation through a
layer of silicone oil (see technical details in Ref. [22]). This
procedure allowed calculation of the radioactivity accumu-
lated within the intracellular compartment and yielded a
volume of 3.7 ± 0.4 ml/mg dry weight (n = 5). This volume
was not altered significantly in B16M-F10 cells isolated from
PTER- and/or QUER-treated mice (not shown).
In conclusion, this is the first time that in vivo administra-
tion of natural polyphenols shows inhibition of metastatic
growth of a highly malignant tumor and extension of host
survival.
Discussion
Bioavailability and in vivo biologic efficacy are critical issues
that must be correlated before drawing any conclusion on the
potential health benefits of polyphenols [14,33,38]. As shown
in Figure 2, where t-RESV, t-PTER, or QUER was tested,
inhibition of B16M-F10 cell proliferation in vitro was stronger
in the presence of t-PTER and QUER. Bioavailable concen-
trations of PTER and QUER, measured in plasma after oral
administration, failed to inhibit B16M-F10 cell growth (even
when concentrations of these polyphenols were constant
along the culture time; see Inhibition of B16 Melanoma Cell
Growth In Vitro section). However, bioavailable concentra-
tions of PTER and QUER, measured in plasma after intra-
venous administration (Figure 1), inhibited tumor growth up
tof56% (even when both polyphenols were present only for
60 minutes for each 24 hours of culture) (Figure 2) without
increasing the rate of cell death (cell viability remained > 95%,
as in controls, in all cases). These experimental facts sug-
gest that PTER and QUER may act as rapid molecular
signals interfering, in a concentration-dependent fashion, in
the mechanism of cell division. As described under Results
section, most cultured B16M-F10 cells accumulated in G0/
G1 in the presence of t-PTER and QUER. In fact, RESV
(< 100 mM), the nonmethoxylated analog of PTER, also
causes growth inhibition in a cell death– independent mech-
anism (see Ref. [39] for a review). For instance, in the
presence of t-RESV, p53-, and p16-deficient CEM-C7H2,
lymphocytic leukemia cells or human epidermoid carcinoma
cells underwent G0/G1 phase arrest (as it occurs with the
B16M-F10 melanoma model); whereas HL-60, human pros-
tate cancer, human breast carcinoma, Caco-2, or rat and
human hepatoma cell lines became arrested at S-phase [39].
Potential possible mechanisms for this growth-inhibitory
activity are mentioned in the introduction. However, QUER
arrests human leukemic T cells in G1 [40] and MCF-7 human
breast cancer cells in G2/M; whereas in ovarian carcinoma
cells, QUER attacks the cell cycle at the G1 and S phase
boundary and inhibits 1-phosphatidylinositol 4-kinase activity
[41]. Furthermore, it has been shown in human OCM-1
melanoma cells that the presence of a hydroxyl group at
the 3V-position of the B-ring in QUER correlated to a G1 cell
cycle arrest, whereas its absence in, for example, kaemp-
ferol or apigenin correlated to a G2 block [42]. This suggests,
as it was proven in the case of RESV [15], that specific
structural determinants are responsible for the antioxidant
activity and the cell cycle effects of QUER. Moreover, as
suggested above, there is an emerging view that flavonoids
and their in vivo metabolites, and likely other polyphenols,
may also exert modulatory effects in cells acting on, for
example, phosphoinositide 3-kinase, Akt/protein kinase B,
tyrosine kinases, protein kinase C, or mitogen-activated
protein kinase signalling cascades [43]. Naturally, analysis
of the signalling activity of PTER and QUER, although far
beyond the aim of the present report, is a very interesting
issue that deserves further studies.
In a previous report, we showed that in vivo administration
of t-RESV (e.g., 20 mg/kg body weight given orally twice per
day) was capable of decreasing B16M-F10metastatic growth
in the liver but without extending host survival [14]. RESV
inhibited VCAM-1 expression in endothelial cells and, there-
by, decreased the rate of the adhesion between metastatic
and the vascular endothelium [14]. However, RESV did not
affect endothelium-induced tumor cytotoxicity [14], and may
possibly cause clonal selection of highly proliferating and
resistant cancer cells (Refs. [20,44] and references therein).
Based on these facts, on the differences in bioavailability, and
on the data shown in Figure 2, we selected the combination of
PTER and QUER to study its effect on metastatic progres-
sion. As shown in Table 3, the effect of t-PTER, QUER,
t-RESV, or their combinations on the in vitro interaction
between B16M-F10 cells and the vascular endothelium was
investigated. Parallel to the effect on B16M-F10 cells growing
in vitro (Figure 2), the association between PTER and QUER
was the best in decreasing the percentage of B16M-F10 cells
adhered to the HSE and in increasing the percentage of
endothelium-induced tumor cytotoxicity (Table 3). In conse-
quence, t-PTER and QUER decreased byf74% the forma-
tion of tumor colonies in an in vitro test of invasion (Table 3).
The antimetastatic mechanisms include inhibition of VCAM-1
expression in the HSE by PTER (possibly mediated by NO if
PTER works as RESV-inducing nitric oxide synthase) [45],
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which consequently decreases B16M-F10 cell adhesion to
the endothelium through VLA-4 (Table 4); and QUER- and
PTER-induced changes in expression of Bcl-2–related pro-
teins (upregulation of proapoptotic and downregulation of
antiapoptotic proteins) in B16M-F10 cells (Table 5), which
sensitizes them to HSE-induced cytotoxicity (Table 6).
Selectins, integrins, cadherins, and immunoglobulins, as
well as unclassified molecules, have been demonstrated to
govern the adhesive interactions between metastatic cells
and the vascular endothelium. Initial contact between meta-
static cells and the endothelium (‘‘docking’’) is weak and
transient, and likely mediated by carbohydrate–carbohy-
drate recognition [34]. The mechanism of B16M-HSE inter-
action includes mannose receptor–mediated melanoma cell
attachment to the HSE, which subsequently causes cytokine
(TNFa, IL-1B, and IL-18) and NO/H2O2 release, VCAM-1–
dependent adherence (reinforcing or ‘‘locking’’ the initial
intercellular binding), and melanoma growth factors release
by the HSE [46]. Involvement of the VLA-4 integrin on
melanoma locking adhesion to endothelial through VCAM-
1 is a well-described mechanism. For instance, Garofalo
et al. [47] showed that A375M human melanoma cells
expressed high levels of VLA-4 and preferentially adhered
to a surface coated with vascular cell adhesion molecule 1
(VCAM-1), the ligand for VLA-4 on activated endothelial
cells. Thus, we focussed on VLA-4 and VCAM-1 as a critical
step in the mechanisms preceding B16M invasion. Never-
theless, this is not excluding per se other molecular mecha-
nisms applying to this model, or other intercellular adhesion
molecules binding other types of metastatic cells to the
vascular endothelium [34]. To answer which is the relative
importance of VCAM-1/VLA-4 interaction between HSE and
B16M-F10 cells, we used two parallel approaches. We
administered antimouse VCAM-1 monoclonal antibodies
(50 mg) intraportally to mice 60 minutes before B16M-F10
inoculation. This caused an 89% decrease in the number of
arrested cancer cells in the liver sinusoids (from 45 ± 7 to 5
± 2; n = 4, P < .01; Table 6). Besides, when B16M-F10 cells
were preincubated for 1 hour in the presence of antimouse
VLA-4 monoclonal antibodies (106 cells/mg antibody) before
inoculation, the number of arrested cancer cells in the
microvasculature also decreased by an 85% (from 45 ± 7
to 7 ± 3, n = 4, P < .01; Table 6).
Bcl-2 overexpression prevents the QUER- and PTER-
dependent increase in metastatic B16M-F10 cell death
caused by the HSE in vivo (Table 6). Thus, Bcl-2 itself
appears as a critical regulator of B16M-F10 resistance
against HSE-induced damage. In vitro experiments have
shown that QUER is an apoptosis inducer in, for example,
human promyeloleukemic HL-60 cells [48] or BL6 murine
melanoma cells [49], although only in BL6 cells was a QUER-
dependent downregulation of Bcl-2 expression suggested as
a causal agent. Furthermore, given the structural relationship
between PTER and RESV, these results also appear in
agreement with others reporting inhibition of RESV-induced
apoptosis by Bcl-2, and downregulation of Bcl-2 and upregu-
lation of BAX upon exposure to RESV [50]. Although recent
data suggest that RESV-mediated apoptosis is independent
of BAX (as suggested above; Table 6), as gene knockout of
BAX did not alter tumor cell sensitivity to RESV [3,51]. In
addition, other potential antimetastatic effects of PTER and
QUER need to be explored (e.g., interestingly, RESV and
QUER have been shown to inhibit angiogenesis in vitro in
a concentration-dependent manner) (6–100 mM) [52].
Can possible clinical applications be derived from our
study? To show that natural polyphenols, such as t-PTER
and QUER, inhibit in vivo metastatic growth of a highly
malignant tumor leading to longer host survival, we used
daily intravenous administration of high doses (20 mg/kg
body weight administered once a day). However, at this
point, different protocols must be naturally considered. For
instance, if it is shown to be more effective and nontoxic for
humans, the dosing could be scaled up. In addition, our
results do not rule out possible benefits of using oral admin-
istration. In fact, t-RESV inhibits VCAM-1 expression at very
low concentrations (1 mM) [14]. Nevertheless, as remarked
by Goldberg et al. [33] and taking into account the in vivo
metabolism of these small polyphenols (e.g., Refs. [53,54]),
investigations of this nature should focus upon the benefits of
their conjugates (e.g., glucuronides and sulfates). Moreover,
doses required to inhibit metastatic growth may depend on
the cell type. Besides, association of t-PTER and QUER
could also be useful in other oxidative stress-related pathol-
ogies (e.g., diabetes, arteriosclerosis, neurodegenerative
diseases, or ischemic heart) [55] where doses required to
obtain benefits could be similar or entirely different.
In conclusion, our findings open a new window for possi-
ble applications of polyphenol associations in cancer thera-
py. Moreover, because polyphenol administration can be
combined with biotherapy, cytotoxic drugs, and/or ionizing
radiation, the mechanisms described in this report may
have useful applications to improve therapy against meta-
static melanoma and, possibly, against other malignant tu-
mor types.
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